Medical Devices Industry Reports Molecular Imaging Market | Page 2

REPORT DESCRIPTION
Molecular Imaging Market – Overview
Molecular imaging technology is used for characterization and measurement of biological processes at the
cellular and molecular level by using imaging detectors. Molecular imaging offers more personalized
approach to evaluation and management of cardiovascular disease conditions, such as atherosclerosis, heart
failure, ischemic injury, thrombosis, and left ventricular remodeling. The technology has become an integral
part of standard care for many types of cancer including breast, lung, and gastrointestinal cancer.
Majority of the molecular imaging procedures involve an imaging device and an imaging agent or probe. A
variety of imaging agents are used to visualize cellular activity, such as the blood flow, oxygen use, and
chemical processes involved in metabolism. In nuclear medicine, a branch of molecular imaging, radiotracer
is used as an imaging agent that include a radioactive atom or isotope. Other molecular imaging modalities,
such as optical imaging and molecular ultrasound, use a variety of different agents. Magnetic resonance
spectroscopy is able to measure chemical levels in the body, without the use of an imaging agent.
The global molecular imaging market was valued at US$ 3.8 billion in 2017, and is expected to witness a
CAGR of 8.1% over the forecast period (2018 – 2026).
© Coherent market Insights. All Rights Reserved